Sihyeong Park

Sihyeong Park

Auto-generated profile, based on publicly available information

Sihyeong Park

Department of Neurology Mayo Clinic Rochester Minnesota USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
GJGong-Jun Ji
Gong-Jun Ji
MFMichael D. Fox
Michael D. Fox
MMMae Morton-Dutton
Mae Morton-Dutton
YWYingru Wang
Yingru Wang
JSJinmei Sun
Jinmei Sun
FSFrederic L. W. V. J. Schaper
Frederic L. W. V. J. Schaper
Idiopathic generalized epilepsy (IGE) is a brain network disease, but the location of this network and its relevance for treatment remain unclear. We combine the locations of brain abnormalities in IGE (131 coordinates from 21 studies) with the human connectome to identify an IGE network. We validate this network by showing alignment with structural brain abnormalities previously identified in IGE and brain areas activated by generalized epileptiform discharges in simultaneous electroencephalogram-functional magnetic resonance imaging. The topography of the IGE network aligns with brain networks involved in motor control and loss of consciousness consistent with generalized seizure semiology. To investigate therapeutic relevance, we analyze data from 21 patients with IGE treated with deep brain stimulation (DBS) for generalized seizures. Seizure frequency reduced a median 90% after DBS and stimulation sites intersect an IGE network peak in the centromedian nucleus of the thalamus. Together, this study helps unify prior findings in IGE and identify a brain network target that can be tested in clinical trials of brain stimulation to control generalized seizures.

14 September 2024 in Epilepsia
Verified
Journal Article
Closed access
SPSihyeong Park
Sihyeong Park
FPFiona Permezel
Fiona Permezel
SAShruti Agashe
Shruti Agashe
GOGamaleldin Osman
Gamaleldin Osman
Hugh David SimpsonHugh David Simpson
Hugh David Simpson
NGNicholas M. Gregg
Nicholas M. Gregg

1 January 2021 in Epilepsy & Behavior Reports
Verified
Journal Article
Open access
SPSihyeong Park
Sihyeong Park
HMHaroon Majoka
Haroon Majoka
ASAjaz Sheikh
Ajaz Sheikh
IAImran Ali
Imran Ali

7 October 2025 in Epilepsia
Verified
Journal Article
Closed access
SPSihyeong Park
Sihyeong Park
JCJordan S. Clark
Jordan S. Clark
PVPedro Viana
Pedro Viana
JCJie Cui
Jie Cui
JDJonas Duun-Henriksen
Jonas Duun-Henriksen
BBBenjamin H. Brinkmann
Benjamin H. Brinkmann

17 February 2021 in Cureus
Verified
Journal Article
Open access
PDF file
SPSihyeong Park
Sihyeong Park
JDJonathan Doan
Jonathan Doan
ISIrfan Sheikh
Irfan Sheikh
ASAjaz A Sheikh
Ajaz A Sheikh
IgLON-5 antibody syndrome has a myriad of clinical presentations, including gait instability, movement disorders, abnormal eye movements, bulbar symptoms, sleep disorders, neuropsychiatric symptoms, dysautonomia, and peripheral neuropathy. Abnormal magnetic resonance imaging (MRI) findings have also been reported such as leukoariotic changes and cerebral and cerebellar atrophy. We present a case of IgLON-5 antibody syndrome with a unique MRI finding of persistent leptomeningeal enhancement. A close follow-up would be warranted as the progression of the disease may be indolent.

1 August 2026 in Epilepsia
Verified
Journal Article
Closed access
PDF file
GOGloria Ortiz‐Guerrero
Gloria Ortiz‐Guerrero
ATAsra Tanwir
Asra Tanwir
AFAshar Farooqi
Ashar Farooqi
SPSihyeong Park
Sihyeong Park
GOGamaleldin Osman
Gamaleldin Osman
NGNicholas M. Gregg
Nicholas M. Gregg